Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells

References

• Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54(5):631–651.
   PubMed Web of Science ®Google Scholar
• Misra R, Acharya S, Sahoo SK. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today. 2010;15(19–20):842–850.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1-2):271–284.
   PubMed Web of Science ®Google Scholar
• Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63(3):170–183.
   PubMed Web of Science ®Google Scholar
• Kamaly N, Xiao Z, Valencia PM, et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012;41(7):2971–3010.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Meng F, Deng C, et al. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. Biomacromolecules. 2014;15(6):1955–1969.
   PubMed Web of Science ®Google Scholar
• Eiznhamer DA, Xu ZQ. Betulinic acid: a promising anticancer candidate. IDrugs. 2004;7(4):359–373.
   PubMedGoogle Scholar
• Clarkson BD, Burchenal JH. Preliminary screening of antineoplasic drugs. Prog Clin Cancer. 1965;1:625–629.
   Google Scholar
• Fulda S, Friesen C, Los M, et al. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 1997;57(21):4956–4964.
   PubMed Web of Science ®Google Scholar
• Pisha E, Chai H, Lee IS, et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med. 1995;1(10):1046–1051.,
   PubMed Web of Science ®Google Scholar
• Rabi T, Shukla S, Gupta S. Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells. Mol Carcinog. 2008;47(12):964–973.
   PubMed Web of Science ®Google Scholar
• Yao N, Li YJ, Lei YH, et al. A piperazidine derivative of 23-hydroxy betulinic acid induces a mitochondria-derived ROS burst to trigger apoptotic cell death in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2016;35(1):192
   PubMedGoogle Scholar
• Cheng Y, Shao Y, Yan W. Solubilities of Betulinic acid in thirteen organic solvents at different temperatures. J Chem Eng Data. 2011;56(12):4587–4591.
   Web of Science ®Google Scholar
• Zuco V, Supino R, Righetti SC, et al. Selective cytotoxicity of betulinic acid on tumor cell lines but not on normal cells. Cancer Lett. 2002;175(1):17–25.
   PubMed Web of Science ®Google Scholar
• Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med. 2015;12(2):106–116.
   PubMed Web of Science ®Google Scholar
• Oakman C, Viale G, Di Leo A. Management of triple negative breast cancer. Breast. 2010;19(5):312–321.
   PubMed Web of Science ®Google Scholar
• Weber D, Zhang M, Zhuang P, et al. The efficacy of betulinic acid in triple-negative breast cancer. SAGE Open Med. 2014;2:01–12.
   Google Scholar
• Vorland LH. Lactoferrin: a multifunctional glycoprotein. APMIS. 1999;107(11):971–981.
   PubMed Web of Science ®Google Scholar
• Högemann-Savellano D, Bos E, Blondet C, et al. The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia. 2003;5(6):495–506.
   PubMed Web of Science ®Google Scholar
• Henry KE, Dilling TR, Abdel-Atti D, et al. Noninvasive 89Zr-transferrin PET shows improved tumor targeting compared with 18F-FDG PET in MYC-overexpressing human triple-negative breast cancer. J Nucl Med. 2018;59(1):51–57.
   PubMed Web of Science ®Google Scholar
• Fujita K, Matsuda E, Sekine K, et al. Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. Cancer Lett. 2004;213(1):21–29.
   PubMed Web of Science ®Google Scholar
• Xu XX, Jiang HR, Li HB, et al. Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin. J Dairy Sci. 2010;93(6):2344–2350.
   PubMed Web of Science ®Google Scholar
• Kumar R, Kumar S, Gogia A, et al. Laryngeal metastases from breast cancer: a rare clinical entity. Curr Probl Cancer. 2019;43(2):130–134.
   PubMed Web of Science ®Google Scholar
• Das S, Roy P, Pal R, et al. Engineered silybin nanoparticles educe efficient control in experimental diabetes. PLOS One. 2014;9(7):e101818
   PubMed Web of Science ®Google Scholar
• Roy P, Das S, Mondal A, et al. Nanoparticle engineering enhances anticancer efficacy of andrographolide in MCF-7 cells and mice bearing EAC. Curr Pharm Biotechnol. 2012;13(15):2669–2681.
   PubMed Web of Science ®Google Scholar
• Zhao G, Yan W, Cao D. Simultaneous determination of betulin and betulinic acid in white birch bark using RP-HPLC. J Pharm Biomed Anal. 2007;43(3):959–962.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55–63.
   PubMed Web of Science ®Google Scholar
• Loos C, Syrovets T, Musyanovych A, et al. Amino-functionalized nanoparticles as inhibitors of mTOR and inducers of cell cycle arrest in leukemia cells. Biomaterials. 2014;35(6):1944–1953.
   PubMed Web of Science ®Google Scholar
• Pozo-Guisado E, Alvarez-Barrientos A, Mulero-Navarro S, et al. The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem Pharmacol. 2002;64(9):1375–1386.
   PubMed Web of Science ®Google Scholar
• Xiao B, Zhang M, Viennois E, et al. Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles. Biomaterials. 2015;48:147–160.
   PubMed Web of Science ®Google Scholar
• Voigt J, Christensen J, Shastri VP. Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc Natl Acad Sci USA. 2014;111(8):2942–2947.
   PubMed Web of Science ®Google Scholar
• Du JR, Long FY, Chen C. Research progress on natural triterpenoid saponins in the chemoprevention and chemotherapy of cancer. Enzymes. 2014;36:95–130.
   PubMedGoogle Scholar
• Wick W, Grimmel C, Wagenknecht B, et al. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J Pharmacol Exp Ther. 1999;289(3):1306–1312.
   PubMed Web of Science ®Google Scholar
• Staros JV, Wright RW, Swingle DM. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem. 1986;156(1):220–222.
   PubMed Web of Science ®Google Scholar
• Cintǎ Pînzaru S, Leopold N, Kiefer W. Vibrational spectroscopy of betulinic acid HIV inhibitor and of its birch bark natural source. Talanta. 2002;57:625–631.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25–35.
   Web of Science ®Google Scholar
• Mehra NK, Mishra V, Jain NK. Receptor-based targeting of therapeutics. Ther Deliv. 2013;4(3):369–394.
   PubMedGoogle Scholar
• Nosrati H, Adinehvand R, Manjili HK, et al. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line. Pharm Dev Technol. 2019;24(1):89–98.
   PubMed Web of Science ®Google Scholar
• Dufes C, Al Robaian M, Somani S. Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells. Ther Deliv. 2013;4(5):629–640.
   PubMedGoogle Scholar
• Ward PP, Conneely OM. Lactoferrin: role in iron homeostasis and host defense against microbial infection. Biometals. 2004;17(3):203–208.
   PubMed Web of Science ®Google Scholar
• Shankaranarayanan JS, Kanwar JR, Al-Juhaishi AJ, et al. Doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in TRAMP mice. Sci Rep. 2016;6(1):32062.
   PubMedGoogle Scholar
• Kuo YC, Chen YC. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles. Int J Pharm. 2015;479(1):138–149.
   PubMedGoogle Scholar
• Oh SM, Pyo CW, Kim Y, et al. Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade. Oncogene. 2004;23(50):8282–8291.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Kamalapuram SK, Krishnakumar S, et al. Multimodal iron oxide (Fe3O4)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER(–)/PR(–)/HER2(–)) –). Nanomedicine. 2016;11(3):249–268.
   PubMed Web of Science ®Google Scholar